<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201103176085N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2011-04-16</date_registration>
      <primary_sponsor>University of Malaya</primary_sponsor>
      <public_title>The impact of the Applied Progressive Muscle Relaxation Training to the level of Depression, Anxiety, Stress and Quality of Life among Prostate Cancer Patients</public_title>
      <acronym>Applied Progressive Muscle Relaxation Training, Depression, Anxiety, Stress, Prostate Cancer</acronym>
      <scientific_title>The impact of the Applied Progressive Muscle Relaxation Training to the level of Depression, Anxiety, Stress and Quality of Life among Prostate Cancer Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2011-05-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>154</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/6538</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Used, Assignment: Other, Purpose: Supportive, Other design features: Quasi-Experimental Study.</study_design>
      <phase>0 (exploratory trials)</phase>
      <hc_freetext>prostate cancer patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group :   &#13;
&#13;
The applied progressive muscle relaxation training (APMRT) therapy that is provided to the intervention group included three 50-minute group education sessions over 6 weeks. The therapy iss given at the rehabilitation clinic or at the patients’ house if they unable to go the hospital during home visit.&#13;
&#13;
During the training, the patient is seated in a quiet room and asked to imitate the different exercises demonstrated by the investigator’s presentations. Each patient is covered with a comfortable blanket and the room lights is then dimmed. Participants in the experimental group are advised to practice the applied relaxation regularly, and they kept daily home relaxation practice records during the study. The patients are refrained from smoking, strenuous physical exercise, eating and consuming caffeine for at least one hour prior to testing.&#13;
&#13;
1   The first session:&#13;
The first session of the training is an introductory group discussion of psychology issues and quality of life in prostate cancer, as well as a rational and general description of the purpose of the relaxation. Each intervention patients is provided a written training manual of PMRT and PMRT picture guide is in order to provide visual illustrations supplementing the therapist’s demonstration for them to make it easier to understand the therapy. &#13;
&#13;
2   The second session:&#13;
The second session is related to teach the patients to do breathing technique in order to enhance more relaxes. The breathing technique took almost 10 minutes to get proper abdominal breathing properly (breathe in for 5 seconds and breathe out for 7 second). It is also to get more oxygen to muscle and tissues. &#13;
&#13;
3   The third session:&#13;
The third session related to relax with the help of a shortened version of progressive relaxation (tense for 5 seconds and relax for 10 seconds) in the 16 large muscle groups of the hands, arms, face, shoulders, back, chest, stomach, breathing, hips, legs, and feet. It also included “release-only” relaxation; this exercise deletes the tensing of the muscle groups to reduce the time it takes the client to become relaxed. It will take around 20 to 30 minutes to complete. The patients in turn demonstrated the relaxation technique using the audiocassette instruction with the instructor’s voice (the audiocassette was provided by the Department of Psychological Medicine, Faculty of Medicine, University of Malaya). &#13;
&#13;
4   The fourth session:&#13;
The fourth session is related to end of the relaxation therapy. It took around 5 minutes to complete. &#13;
&#13;
5   The final session:&#13;
The final session is to start the applied PMRT from the breathing technique, the PMRT and the end of the relaxation therapy. All the session took around 40 to 50 minutes. At the end of the teaching session, the therapist discussed relaxation training with the patients to confirm that they had mastered the technique.&#13;
&#13;
To supplement the presentations and to provide a more effective program, the researchers used posters and provides participants with written material. A pamphlet included general information on depression, anxiety and stress as well as quality of life in prostate cancer. Patient will giving the audiocassette with the instruction home with them to practice APMRT twice daily throughout the study period. They are asked to record the relaxation practice on a practical log. &#13;
&#13;
The second therapy is held next two weeks later to reassess the patient’s skill mastery and to discuss their concerns about the APMRT practice. The investigator initiates biweekly telephone calls to encourage the patient’s compliance and clarify related problem. The third therapy iss given to the patients two weeks after the second therapy. The investigator made telephone calls biweekly to ensure the compliance of the patients to the therapy.&#13;
&#13;
After 4 months from the first therapy, the intervention group is asked to complete a questionnaire as the posttest (T1). After the posttest (T1), the intervention group is asked to do the relaxation therapy by their own by using the audiocassette and the script that have been given to them. The after 6 months from the first therapy, once again, the intervention group is asked to complete a questionnaire as the posttest (T2). Intervention 2: Control group:&#13;
The control in a quasi-experimental trial should not give any intervention. However, it was unethical to withhold information which could benefit the subjects. Therefore the control group is given information of about depression, anxiety and stress and minimal health promotion with the principle of better quality of life without having any psychological problem. Telephone calls made biweekly thereafter throughout the 6 months study period in order to avoid missing of follow up.&#13;
&#13;
After 4 months from the first interview, the control group is asked to complete a questionnaire as the posttest (T1). The after 6 months, once again, the control group is asked to complete a questionnaire as the posttest (T2).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohamad Rodi bin Isa</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Social &amp; Preventive Medicine, Faculty of Medicine</address>
        <city>Kuala Lumpur</city>
        <country1>Malaysia</country1>
        <zip>50603</zip>
        <telephone>+603-79674975</telephone>
        <email>mdrodi@siswa.um.edu.my</email>
        <affiliation>University of Malaya</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohamad Rodi bin Isa</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Social &amp; Preventive Medicine, Faculty of Medicine</address>
        <city>Kuala Lumpur</city>
        <country1>Malaysia</country1>
        <zip>50603</zip>
        <telephone>+603-79674975</telephone>
        <email>mdrodi@siswa.um.edu.my</email>
        <affiliation>University of Malaya</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Malaysia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria&#13;
&#13;
i.	Patients diagnosed with prostate cancer confirmed by the histology of prostate gland cell.&#13;
ii.	Patients with 50 years old and above.&#13;
&#13;
Exclusion criteria&#13;
&#13;
i.	Patients who have been diagnosed any cancer other than prostate cancer&#13;
ii.	Patients who have been diagnosed with any psychiatric diagnosis&#13;
iii.	Patients who are currently use of psychiatric medication&#13;
iv.	Patients who are having prior training or current use of relaxation therapy&#13;
v.	Patients who have presence of physical limitations for learning Progrressive Muscle Relaxation Training (eg: bed-bound)&#13;
vi.	Patients who did not understand Bahasa Malaysia and English&#13;
vii.	Patients with no contact number</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>90 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C61</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>C61   Malignant neoplasm of prostate</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group :   &#13;
&#13;
The applied progressive muscle relaxation training (APMRT) therapy that is provided to the intervention group included three 50-minute group education sessions over 6 weeks. The therapy iss given at the rehabilitation clinic or at the patients’ house if they unable to go the hospital during home visit.&#13;
&#13;
During the training, the patient is seated in a quiet room and asked to imitate the different exercises demonstrated by the investigator’s presentations. Each patient is covered with a comfortable blanket and the room lights is then dimmed. Participants in the experimental group are advised to practice the applied relaxation regularly, and they kept daily home relaxation practice records during the study. The patients are refrained from smoking, strenuous physical exercise, eating and consuming caffeine for at least one hour prior to testing.&#13;
&#13;
1   The first session:&#13;
The first session of the training is an introductory group discussion of psychology issues and quality of life in prostate cancer, as well as a rational and general description of the purpose of the relaxation. Each intervention patients is provided a written training manual of PMRT and PMRT picture guide is in order to provide visual illustrations supplementing the therapist’s demonstration for them to make it easier to understand the therapy. &#13;
&#13;
2   The second session:&#13;
The second session is related to teach the patients to do breathing technique in order to enhance more relaxes. The breathing technique took almost 10 minutes to get proper abdominal breathing properly (breathe in for 5 seconds and breathe out for 7 second). It is also to get more oxygen to muscle and tissues. &#13;
&#13;
3   The third session:&#13;
The third session related to relax with the help of a shortened version of progressive relaxation (tense for 5 seconds and relax for 10 seconds) in the 16 large muscle groups of the hands, arms, face, shoulders, back, chest, stomach, breathing, hips, legs, and feet. It also included “release-only” relaxation; this exercise deletes the tensing of the muscle groups to reduce the time it takes the client to become relaxed. It will take around 20 to 30 minutes to complete. The patients in turn demonstrated the relaxation technique using the audiocassette instruction with the instructor’s voice (the audiocassette was provided by the Department of Psychological Medicine, Faculty of Medicine, University of Malaya). &#13;
&#13;
4   The fourth session:&#13;
The fourth session is related to end of the relaxation therapy. It took around 5 minutes to complete. &#13;
&#13;
5   The final session:&#13;
The final session is to start the applied PMRT from the breathing technique, the PMRT and the end of the relaxation therapy. All the session took around 40 to 50 minutes. At the end of the teaching session, the therapist discussed relaxation training with the patients to confirm that they had mastered the technique.&#13;
&#13;
To supplement the presentations and to provide a more effective program, the researchers used posters and provides participants with written material. A pamphlet included general information on depression, anxiety and stress as well as quality of life in prostate cancer. Patient will giving the audiocassette with the instruction home with them to practice APMRT twice daily throughout the study period. They are asked to record the relaxation practice on a practical log. &#13;
&#13;
The second therapy is held next two weeks later to reassess the patient’s skill mastery and to discuss their concerns about the APMRT practice. The investigator initiates biweekly telephone calls to encourage the patient’s compliance and clarify related problem. The third therapy iss given to the patients two weeks after the second therapy. The investigator made telephone calls biweekly to ensure the compliance of the patients to the therapy.&#13;
&#13;
After 4 months from the first therapy, the intervention group is asked to complete a questionnaire as the posttest (T1). After the posttest (T1), the intervention group is asked to do the relaxation therapy by their own by using the audiocassette and the script that have been given to them. The after 6 months from the first therapy, once again, the intervention group is asked to complete a questionnaire as the posttest (T2)</i_keyword>
      <i_keyword>Control group:&#13;
The control in a quasi-experimental trial should not give any intervention. However, it was unethical to withhold information which could benefit the subjects. Therefore the control group is given information of about depression, anxiety and stress and minimal health promotion with the principle of better quality of life without having any psychological problem. Telephone calls made biweekly thereafter throughout the 6 months study period in order to avoid missing of follow up.&#13;
&#13;
After 4 months from the first interview, the control group is asked to complete a questionnaire as the posttest (T1). The after 6 months, once again, the control group is asked to complete a questionnaire as the posttest (T2).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The impact of Applied progressive muscle relaxation training to the level of depression, anxietyand stress. Timepoint: after 6 months from the first intervention. Method of measurement: Using DASS scale score.</prim_outcome>
      <prim_outcome>The impact of the Appplied Progressive muscle relaxation training to the level of quality of life. Timepoint: after 6 months fro mthe first intervention. Method of measurement: SF-36 Quality of life questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>To determine the pattern and characteristics  in the study population. Timepoint: at the baseline data collected. Method of measurement: the socio-demographic, past medical and surgical illness, urological sign and symptoms and the status of the prostate cancer.</sec_outcome>
      <sec_outcome>To assess the quality of life among the study population. Timepoint: After the baseline data collected. Method of measurement: SF-36 quality of life questionnaire.</sec_outcome>
      <sec_outcome>To determine prevalence of depression, anxiety and stress among prostate cancer patient. Timepoint: at the baseline data collected. Method of measurement: by using DASS scale score.</sec_outcome>
      <sec_outcome>To describe the differences of the quality of life between the depression, anxiety and stress status in the study population. Timepoint: At the baseline data collected. Method of measurement: DASS scale score and SF-36 Quality of life questionnnaire.</sec_outcome>
      <sec_outcome>To determine the correlation between depression, anxiety and stress level among study population. Timepoint: At the baseline data collected. Method of measurement: DASS sccale score and SF-36 Quality of life Questionnaires.</sec_outcome>
      <sec_outcome>To compare the quality of life of the metastases status among prostate cancer patients. Timepoint: At the baseline data collected. Method of measurement: SF-36 quality of life questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Malaya</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2010-04-23</approval_date>
        <contact_name>University Malaya Medical Centre (UMMC) Medical Research Ethic Committee</contact_name>
        <contact_address>University Malaya Medical Centre Kuala Lumpur Wilayah Persekutuan Malaysia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
